Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): a hypothesis

M Mehta, P Prasher, M Sharma, MD Shastri… - Medical hypotheses, 2020 - Elsevier
The highly contagious coronavirus, which had already affected more than 2 million people in
210 countries, triggered a colossal economic crisis consequently resulting from measures …

Nanotechnology for COVID-19: therapeutics and vaccine research

G Chauhan, MJ Madou, S Kalra, V Chopra, D Ghosh… - ACS …, 2020 - ACS Publications
The current global health threat by the novel coronavirus disease 2019 (COVID-19) requires
an urgent deployment of advanced therapeutic options available. The role of …

[HTML][HTML] Nanomedicine strategies to target coronavirus

MA Heinrich, B Martina, J Prakash - Nano Today, 2020 - Elsevier
With the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, the middle
east respiratory syndrome CoV (MERS-CoV) in 2012 and the recently discovered SARS …

Nanocarrier vaccines for SARS-CoV-2

J Machhi, F Shahjin, S Das, M Patel… - Advanced Drug Delivery …, 2021 - Elsevier
The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death
associated with substantive social, economic and societal impacts. Treatments rely on re …

Can nanotechnology help in the fight against COVID-19?

G Palestino, I García-Silva… - Expert review of anti …, 2020 - Taylor & Francis
Introduction The current COVID-19 pandemic caused by the SARS-CoV-2 virus demands
the development of strategies not only to detect or inactivate the virus, but to treat it …

Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2

SN Tammam, S El Safy, S Ramadan, S Arjune… - Journal of Controlled …, 2021 - Elsevier
Abstract The coronavirus disease-19 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV2) has taken the world by surprise. To date, a …

The potential role of nanomedicine on COVID-19 therapeutics

RM Mainardes, C Diedrich - Therapeutic Delivery, 2020 - Taylor & Francis
Conclusion To date, there are no specific approved drugs for treating SARS-CoV-2, and
vaccines are under clinical trials. All efforts are welcome to combat the virus, and nanotech …

Insights from nanotechnology in COVID-19 treatment

Z Tang, X Zhang, Y Shu, M Guo, H Zhang, W Tao - Nano today, 2021 - Elsevier
In just a few months, SARS-CoV-2 and the disease it causes, COVID-19, created a
worldwide pandemic. Virologists, biologists, pharmacists, materials scientists, and clinicians …

Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2

S Kamat, M Kumari, C Jayabaskaran - Journal of Controlled Release, 2021 - Elsevier
The recent outbreak of SARS-CoV-2 has forever altered mankind resulting in the COVID-19
pandemic. This respiratory virus further manifests into vital organ damage, resulting in …

Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination

M Pereira-Silva, G Chauhan, MD Shin… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a particular
coronavirus strain responsible for the coronavirus disease 2019 (COVID-19), accounting for …